Anivive Lifesciences Unveils Breakthrough Research on Valley Fever Vaccine at World Vaccine Congress 2025 Dr. Edward Robb showcased Anivive's cutting-edge Valley Fever vaccine research at the World Vaccine Congress 2025, marking a potential breakthrough in antifungal vaccine development.

Anivive Lifesciences Unveils Breakthrough Research on Valley Fever Vaccine at World Vaccine Congress 2025 #United_States #Washington,_D.C. #Anivive #Valley_Fever #Edward_Robb